Clinical Trial

Allogeneic Use of Expanded Mesenchymal Stem Cells Derived From Adipose Tissue (HC106), Female Urinary Incontinence Women Over 50 Years Old

Study acronym: SUITH)
Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated May 1, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Evaluate the feasibility and safety, obtaining initial efficacy data, of expanded allogeneic mesenchymal stem cells derived from adipose tissue (HC106) for the treatment of urinary incontinence in women over 50 years of age.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-16.
Status change: Not Yet Recruiting → Recruiting 2025-04-29
Trial Details
NCT Number NCT06738576
Lead Sponsor Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Conditions Urinary Incontinence Stress
Enrollment 60 participants
Start Date 2024-12-16
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-01